Jialiang Yang

A dual-tower multimodal framework with feature quality enhancement for predicting pathological complete response after neoadjuvant chemotherapy in breast cancer: a multicenter study

BACKGROUND: Pathological complete response (pCR) is a key endpoint following neoadjuvant chemotherapy (NAC) in breast cancer, with potential to guide treatment adaptation and surgical de-escalation. However, limited generalizability across institutions remains a major challenge d...